US 12415794
Pyridazinone compounds and uses thereof
granted A61KA61K31/4525A61K31/501
Quick answer
US patent 12415794 (Pyridazinone compounds and uses thereof) held by EDGEWISE THERAPEUTICS, INC. expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EDGEWISE THERAPEUTICS, INC.
- Grant date
- Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/4525, A61K31/501, A61K31/573, A61K45/06